Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Life Following Excision of Neuroendocrine Tumors

View source ↗

Summary

An update on a clinical trial studying outcomes after surgical excision of neuroendocrine tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Neuroendocrine (NE) Tumors, Neuroendocrine Tumor GEP Grade 1-3 | Status: RECRUITING